Search Within

Mark Kris

Formats
  1. Journal Article (478)
  2. Meeting Abstract (356)
  3. Conference Paper (16)
  4. Book Section (9)
  5. Review (6)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (870)
  2. Solid Tumor Oncology Division (870)
  3. Thoracic Oncology (870)
  4. Department of Pathology and Laboratory Medicine (318)
  5. GSK Faculty (291)
  6. Human Oncology and Pathogenesis Program (224)

More Groups

People
  1. Gregory Riely (221)
  2. Marc Ladanyi (190)
  3. Vincent Miller (172)
  4. Valerie Rusch (130)
  5. Maria Arcila (123)
  6. Jamie Chaft (107)

More People

Years
  1. 2025 (5)
  2. 2024 (18)
  3. 2023 (27)
  4. 2022 (21)
  5. 2021 (21)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (235)
  2. Journal of Thoracic Oncology (131)
  3. Clinical Cancer Research (65)
  4. Cancer (33)
  5. Lung Cancer (31)
  6. Annals of Oncology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (253)
  2. Elsevier Inc. (179)
  3. American Association for Cancer Research (105)
  4. Oxford University Press (47)
  5. Wiley Blackwell (36)
  6. Elsevier Ireland Ltd. (30)

More Publishers

Results (870)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The psychosocial world of women with advanced lung cancer
    Meeting Abstract

    Holland, J. C.; Gooen-Piels, J.; Zuckerman, E.; Culkin, A.; Kris, M.; Fleishman, S.; Kornblith, A. B.
    Psycho-Oncology (2005)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX, pralatrexate) plus docetaxel in patients with advanced Non-Small Cell Lung Cancer (NSCLC)
    Meeting Abstract

    Gomez, J.; Azzoli, C.; Krug, L.; Ginsberg, M.; Henry, R.; Tyson, L.; Pizzo, B.; Dunne, M.; Kris, M.; Sirotnak, F.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with small cell lung cancer (SCLC)
    Meeting Abstract

    Chen, L. C.; Krug, L. M.; Azzoli, C. G.; Park, S. J.; Gomez, J.; Danenberg, K.; Danenberg, P.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Biomarkers for small cell lung cancer (SCLC): DNA methylation and GD2 synthase transcript levels
    Meeting Abstract

    Chen, L.; Krug, L.; Azzoli, C.; Cheung, I.; Park, S.; Danenberg, P.; Danenberg, K.; Cheung, N.; Kris, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with metastatic non-small cell lung cancer (NSCLC) before, and after chemotherapy, as potential biomarkers for response to treatment
    Meeting Abstract

    Azzoli, C. G.; Park, S.; Gomez, J.; Krug, L.; Miller, V.; Rizvi, N.; Ben-Porat, L.; Danenberg, K.; Danenberg, P.; Kris, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Practical management of patients with non-small-cell lung cancer treated with gefitinib
    Journal Article

    Shah, N. T.; Kris, M. G.; Pao, W.; Tyson, L. B.; Pizzo, B. M.; Heinemann, M. H.; Ben-Porat, L.; Sachs, D. L.; Heelan, R. T.; Miller, V. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial
    Journal Article

    Cella, D.; Herbst, R. S.; Lynch, T. J.; Prager, D.; Belani, C. P.; Schiller, J. H.; Heyes, A.; Ochs, J. S.; Wolf, M. K.; Kay, A. C.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials
    Journal Article

    Bell, D. W.; Lynch, T. J.; Haserlat, S. M.; Harris, P. L.; Okimoto, R. A.; Brannigan, B. W.; Sgroi, D. C.; Muir, B.; Riemenschneider, M. J.; Iacona, R. B.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save